Citigroup’s Centessa Pharmaceuticals CNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23.9K | Buy |
1,821
+491
| +37% | +$6.45K | ﹤0.01% | 4304 |
|
|
2025
Q1 | $19.1K | Buy |
1,330
+151
| +13% | +$2.17K | ﹤0.01% | 4332 |
|
|
2024
Q4 | $19.7K | Sell |
1,179
-12,915
| -92% | -$216K | ﹤0.01% | 4417 |
|
|
2024
Q3 | $225K | Buy |
14,094
+12,866
| +1,048% | +$206K | ﹤0.01% | 3499 |
|
|
2024
Q2 | $11.1K | Buy |
1,228
+1,024
| +502% | +$9.25K | ﹤0.01% | 4371 |
|
|
2024
Q1 | $2.31K | Sell |
204
-795
| -80% | -$8.98K | ﹤0.01% | 4595 |
|
|
2023
Q4 | $7.95K | Buy |
999
+343
| +52% | +$2.73K | ﹤0.01% | 4484 |
|
|
2023
Q3 | $4.24K | Sell |
656
-239
| -27% | -$1.55K | ﹤0.01% | 4022 |
|
|
2023
Q2 | $5.54K | Buy |
895
+294
| +49% | +$1.82K | ﹤0.01% | 4461 |
|
|
2023
Q1 | $2.31K | Sell |
601
-67
| -10% | -$258 | ﹤0.01% | 4362 |
|
|
2022
Q4 | $2.07K | Hold |
668
| – | – | ﹤0.01% | 4463 |
|
|
2022
Q3 | $3K | Sell |
668
-557
| -45% | -$2.5K | ﹤0.01% | 4573 |
|
|
2022
Q2 | $6K | Buy |
1,225
+314
| +34% | +$1.54K | ﹤0.01% | 4779 |
|
|
2022
Q1 | $8K | Sell |
911
-118
| -11% | -$1.04K | ﹤0.01% | 4837 |
|
|
2021
Q4 | $12K | Buy |
1,029
+820
| +392% | +$9.56K | ﹤0.01% | 4747 |
|
|
2021
Q3 | $3K | Sell |
209
-882
| -81% | -$12.7K | ﹤0.01% | 4869 |
|
|
2021
Q2 | $24K | Buy |
+1,091
| New | +$24K | ﹤0.01% | 4513 |
|